Citi raises target to EUR 47 for Siemens Healthineers stock
Published on 10/15/2026 at 11:21 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWSAnalyst view and earnings schedule
- Citi lifted its Siemens Healthineers target to EUR 47 from EUR 46 on October 13, 2026.
- Third-quarter revenue rose 1.80 percent to EUR 5.76 billion.
- Siemens Healthineers stock trades at EUR 40.22 at 11:13 a.m. CEST at Lang & Schwarz on October 15, 2026, 0.37 percent above the Xetra close of October 14, 2026.
- Fourth-quarter results are scheduled for November 5, 2026.
Siemens Healthineers (ISIN DE000SHL1006) traded at EUR 40.22 at Lang & Schwarz on October 15, 2026 at 11:13 a.m. CEST, 0.37 percent above the Xetra close of October 14, 2026 at EUR 40.07. Citi raised its price target from EUR 46 to EUR 47 on October 13, 2026, according to Markets Insider.
Three events set the context
On July 31, 2026, Siemens Healthineers reported third-quarter revenue of EUR 5.76 billion, up 1.80 percent from EUR 5.66 billion a year earlier. The figures were reported by finanzen.net.
On October 5, 2026, Deutsche Bank maintained a Hold rating and a EUR 39 target, while on October 13, 2026, Citi raised its target to EUR 47 from EUR 46 and kept a Buy rating. Aktiencheck carried the Citigroup details.
What does the guidance change mean?
The latest operating picture combines resilient core businesses with pressure in Diagnostics. In its Q3 call, Yahoo Finance reported that Siemens Healthineers lowered fiscal 2026 comparable revenue growth guidance to 3.5 percent to 4.0 percent, while raising adjusted earnings per share guidance to EUR 2.35 to EUR 2.45 after tariff refunds. The call also cited a 1.27 equipment book-to-bill ratio in the third quarter and a 5.00 percent increase in the Imaging and Precision Therapy core.
That mix explains the different analyst signals. Citi's higher EUR 47 target contrasts with Deutsche Bank's EUR 39 target, leaving execution in Diagnostics and the recovery in China as important valuation factors. Siemens Healthineers said the Q3 margin benefited from tariff refunds, so the quality of earnings remains central to the next report.
When are the next results?
The company's investor-relations calendar lists fourth-quarter fiscal 2026 results and the analyst call for November 5, 2026, followed by a U.S. roadshow on November 6, 2026, according to Siemens Healthineers.
Valuation before the next report
At EUR 40.22, the stock sits between its 52-week low of EUR 32.81 and high of EUR 49.71, based on the same-day EUR quote context. The current market capitalization is EUR 45.0 billion, giving the upcoming results a clear role in testing the targets now spread between EUR 39 and EUR 47. The further course of trading is shown by the continuously updated real-time quote of Siemens Healthineers stock.
Siemens Healthineers stock facts
- Company: Siemens Healthineers AG
- ISIN: DE000SHL1006
- WKN: SHL100
- Ticker: SHL
- Primary exchange: Xetra
- Price Lang & Schwarz (as of October 15, 2026, 11:13 a.m. CEST): EUR 40.22
- Change versus Xetra close: plus 0.37 percent
- Xetra close (October 14, 2026): EUR 40.07
- Market capitalization: EUR 45.0 billion (as of October 15, 2026)
- 52-week range: EUR 32.81-49.71 (as of October 15, 2026)
- Sector / Industry: Health Care / Medical technology
- Index membership: DAX
- Next earnings date: November 5, 2026
Market context: Market report DAX.
